{"id":68758,"date":"2026-02-21T13:56:34","date_gmt":"2026-02-21T13:56:34","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=68758"},"modified":"2026-05-21T07:14:12","modified_gmt":"2026-05-21T07:14:12","slug":"tb-500","status":"publish","type":"product","link":"https:\/\/medsbase.com\/cs\/product\/tb-500\/","title":{"rendered":"TB-500 (Thymosin Beta-4)"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Rychl\u00e1 odpov\u011b\u010f \u2014 Co je TB-500?<\/h3>\n<p style=\"margin: 0;\"><strong>TB-500<\/strong> je syntetick\u00fd analog <strong>Thymosin Beta-4<\/strong>, p\u0159irozen\u011b se vyskytuj\u00edc\u00edho 43-aminokyselinov\u00e9ho peptidu se syst\u00e9movou hojivou aktivitou. V publikovan\u00fdch preklinick\u00fdch studi\u00edch se v\u00e1\u017ee na G-aktin, stimuluje angiogenezi prost\u0159ednictv\u00edm VEGF\/KDR dr\u00e1hy a moduluje z\u00e1n\u011btlivou signalizaci TGF-beta. Dod\u00e1v\u00e1 se v lyofilizovan\u00fdch vialk\u00e1ch o obsahu 2 mg a\u017e 10 mg v\u00fdhradn\u011b pro laboratorn\u00ed v\u00fdzkum.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Co z\u00edsk\u00e1te s MedsBase:<\/strong> V\u00fdzkumn\u00e9 lyofilizovan\u00e9 peptidy \u00b7 HPLC \u010distota \u226599% (COA na vy\u017e\u00e1d\u00e1n\u00ed) \u00b7 Diskr\u00e9tn\u00ed teplotn\u011b stabiln\u00ed balen\u00ed \u00b7 Celosv\u011btov\u00e1 p\u0159eprava peptid\u016f \u00b7 1,400+ ov\u011b\u0159en\u00fdch <a href=\"https:\/\/medsbase.com\/cs\/reviews\/\">recenz\u00ed z\u00e1kazn\u00edk\u016f<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00ed <a href=\"https:\/\/medsbase.com\/cs\/medsbase-re-shipment-assurance-policy\/\"><strong>Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/strong><\/a> \u2014 pokud va\u0161e z\u00e1silka nedoraz\u00ed do 20 pracovn\u00edch dn\u016f, p\u0159epos\u00edl\u00e1me ji.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Specifikace<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detail<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>CAS \u010d\u00edslo<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">77591-33-4<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>item2<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>212<\/sub>H<sub>350<\/sub>N<sub>56<\/sub>O<sub>78<\/sub>S<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>item7<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">~4963 Da (N-acetyl Thymosin \u03b2-4 (1\u201343))<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>item9<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Ac-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>item11<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyofilizovan\u00fd pr\u00e1\u0161ek (nebo v dodan\u00e9 form\u011b)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>item13<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (HPLC ov\u011b\u0159eno, COA na vy\u017e\u00e1d\u00e1n\u00ed)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Skladov\u00e1n\u00ed<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyofilizovan\u00fd: 2\u20138 \u00b0C (lednice) pro pracovn\u00ed z\u00e1sobu; \u221220 \u00b0C pro dlouhodob\u00e9 skladov\u00e1n\u00ed neotev\u0159en\u00fdch vialek. Rekonstituovan\u00fd: 2\u20138 \u00b0C, pou\u017e\u00edt do ~30 dn\u016f. Vyvarujte se prudk\u00e9ho prot\u0159ep\u00e1v\u00e1n\u00ed; velk\u00e9 peptidy se t\u0159ep\u00e1n\u00edm denaturuj\u00ed. Nefreeze\u2013thaw rekonstituovan\u00fd roztok.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Rozpustnost<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Bakteriostatick\u00e1 voda (doporu\u010deno) nebo steriln\u00ed voda pro krat\u0161\u00ed dobu pou\u017eit\u00ed<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Pouze pro v\u00fdzkum<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Pouze pro laboratorn\u00ed v\u00fdzkum. Nen\u00ed ur\u010deno pro diagnostick\u00e9 nebo terapeutick\u00e9 pou\u017eit\u00ed u lid\u00ed nebo zv\u00ed\u0159at.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>Co je TB-500?<\/h2>\n<p><strong>TB-500<\/strong> je laboratorn\u00ed ozna\u010den\u00ed pro syntetick\u00fd analog <strong>Thymosin Beta-4 (TB4)<\/strong>, p\u0159irozen\u011b se vyskytuj\u00edc\u00edho 43-aminokyselinov\u00e9ho peptidov\u00e9ho hormonu p\u0159\u00edtomn\u00e9ho t\u00e9m\u011b\u0159 v ka\u017ed\u00e9 bu\u0148ce lidsk\u00e9ho t\u011bla. TB4 je nejhojn\u011bj\u0161\u00ed v krevn\u00edch desti\u010dk\u00e1ch a uvol\u0148uje se v m\u00edstech po\u0161kozen\u00ed tk\u00e1n\u011b, kde \u0159\u00edd\u00ed migraci bun\u011bk, angiogenezi a protiz\u00e1n\u011btlivou signalizaci. Syntetick\u00e1 v\u00fdzkumn\u00e1 forma \u2014 TB-500 \u2014 reprodukuje biologickou aktivitu TB4 a je nejv\u00edce studovanou v\u00fdzkumnou slou\u010deninou v t\u00e9to t\u0159\u00edd\u011b.<\/p>\n<p>Sekvence TB4 je <em>Ac-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES<\/em>, s molekulovou hmotnost\u00ed p\u0159ibli\u017en\u011b 4 963 Da. Dod\u00e1v\u00e1 se jako vysoce \u010dist\u00fd lyofilizovan\u00fd pr\u00e1\u0161ek pro rekonstituci s bakteriostatickou vodou. TB-500 je <strong>ur\u010den pouze pro laboratorn\u00ed v\u00fdzkum<\/strong> a nen\u00ed ur\u010den pro hum\u00e1nn\u00ed nebo veterin\u00e1rn\u00ed diagnostiku \u010di terapii. Pro mechanismus, podrobnosti publikovan\u00fdch studi\u00ed a d\u00e1vkov\u00e1n\u00ed ve v\u00fdzkumu viz n\u00e1\u0161 kompletn\u00ed <a href=\"https:\/\/medsbase.com\/cs\/tb-500-thymosin-beta-4-peptide-guide\/\">v\u00fdzkumn\u00fd pr\u016fvodce TB-500<\/a>.<\/p>\n<h2>Mechanismus \u00fa\u010dinku \u2014 syst\u00e9mov\u00e9 hojen\u00ed prost\u0159ednictv\u00edm t\u0159\u00ed drah<\/h2>\n<p>TB-500 se od v\u011bt\u0161iny peptid\u016f odli\u0161uje sv\u00fdm <strong>syst\u00e9mov\u00e9 roz\u0161\u00ed\u0159en\u00ed a dlouh\u00fd cirkula\u010dn\u00ed polo\u010das<\/strong>, kter\u00e9 umo\u017e\u0148uj\u00ed jedinou aplikaci ovlivnit reparativn\u00ed procesy v mnoha tk\u00e1n\u00edch sou\u010dasn\u011b. T\u0159i hlavn\u00ed mechanistick\u00e9 dr\u00e1hy podle publikovan\u00e9ho v\u00fdzkumu:<\/p>\n<ul>\n<li><strong>sekvestrace G-aktinu<\/strong> \u2014 TB-500 v\u00e1\u017ee monomern\u00ed aktin (G-aktin) prost\u0159ednictv\u00edm centr\u00e1ln\u00edho aktin-vazebn\u00e9ho motivu (LKKTETQ). T\u00edm se zachov\u00e1v\u00e1 cytoskelet\u00e1ln\u00ed rezerva pot\u0159ebn\u00e1 pro vysunut\u00ed pseudopodi\u00ed, migraci sm\u011brem k m\u00edst\u016fm poran\u011bn\u00ed a remodelaci po po\u0161kozen\u00ed. Testy migrace bun\u011bk ve v\u00fdzkumu okraj\u016f ran opakovan\u011b prokazuj\u00ed zv\u00fd\u0161enou migra\u010dn\u00ed rychlost u bun\u011bk l\u00e9\u010den\u00fdch TB4.<\/li>\n<li><strong>angiogeneze prost\u0159ednictv\u00edm VEGF\/KDR signalizace<\/strong> \u2014 TB-500 stimuluje migraci vaskul\u00e1rn\u00edho endotelu a tvorbu kapil\u00e1r prost\u0159ednictv\u00edm dr\u00e1hy receptoru VEGF 2 (KDR). Ve v\u00fdzkumu ischemie-reperf\u00faze a hojen\u00ed ran se to projevuje rychlej\u0161\u00edm obnoven\u00edm perf\u00faze v m\u00edst\u011b reparace.<\/li>\n<li><strong>protiz\u00e1n\u011btliv\u00e1 signalizace modulac\u00ed TGF-beta<\/strong> \u2014 TB-500 sni\u017euje uvol\u0148ov\u00e1n\u00ed proz\u00e1n\u011btliv\u00fdch cytokin\u016f a urychluje ukon\u010den\u00ed z\u00e1n\u011btliv\u00e9 f\u00e1ze hojen\u00ed. Ve v\u00fdzkumu srde\u010dn\u00ed ischemie je to spojeno se zmen\u0161en\u00edm velikosti infarktu a zachov\u00e1n\u00edm funkce kardiomyocyt\u016f.<\/li>\n<\/ul>\n<p>Proto\u017ee tyto t\u0159i mechanismy p\u016fsob\u00ed v cel\u00e9m t\u011ble, TB-500 vyvol\u00e1v\u00e1 \u00fa\u010dinky i ve tk\u00e1n\u00edch vzd\u00e1len\u00fdch od m\u00edsta injekce \u2014 co\u017e je charakteristick\u00fd rys, kter\u00fd jej odli\u0161uje od lok\u00e1ln\u011b p\u016fsob\u00edc\u00edch hojiv\u00fdch peptid\u016f, jako je <a href=\"https:\/\/medsbase.com\/cs\/bpc-157\/\">BPC-157<\/a>. Praktick\u00fd d\u016fsledek: v\u00fdzkumn\u00e9 protokoly TB-500 se d\u00e1vkuj\u00ed dvakr\u00e1t t\u00fddn\u011b nam\u00edsto denn\u011b.<\/p>\n<h2>Publikovan\u00e9 v\u00fdzkumn\u00e9 aplikace<\/h2>\n<p>TB-500 se pou\u017e\u00edv\u00e1 v laboratorn\u00edm v\u00fdzkumu ke zkoum\u00e1n\u00ed:<\/p>\n<ul>\n<li><strong>Oprava kostern\u00edho svalstva<\/strong> \u2014 syst\u00e9mov\u00e1 kinetika zotaven\u00ed u model\u016f hlodavc\u016f s drtiv\u00fdm poran\u011bn\u00edm, namo\u017een\u00edm a atrofi\u00ed z ne\u010dinnosti<\/li>\n<li><strong>V\u00fdzkum srde\u010dn\u00ed regenerace<\/strong> \u2014 p\u0159e\u017eit\u00ed kardiomyocyt\u016f, velikost infarktu a c\u00e9vn\u00ed remodelace po ischemii (Smart et al., Nature 2011; Bock-Marquette et al., Nature 2004)<\/li>\n<li><strong>Hojen\u00ed \u0161lach a vaz\u016f<\/strong> \u2014 samostatn\u011b nebo v kombinaci s <a href=\"https:\/\/medsbase.com\/cs\/bpc-157\/\">BPC-157<\/a> ve v\u00fdzkumu oprav pojivov\u00e9 tk\u00e1n\u011b<\/li>\n<li><strong>Syst\u00e9mov\u00e1 oprava ran<\/strong> \u2014 v\u00fdzkum hojen\u00ed ko\u017en\u00edch a rohovkov\u00fdch ran, zejm\u00e9na p\u0159i posti\u017een\u00ed v\u00edce tk\u00e1n\u00ed<\/li>\n<li><strong>V\u00fdzkum cyklu r\u016fstu vlas\u016f<\/strong> \u2014 folikul\u00e1rn\u00ed angiogeneze a p\u0159echody mezi f\u00e1zemi r\u016fstu vlas\u016f u v\u00fdzkumn\u00fdch model\u016f hlodavc\u016f<\/li>\n<li><strong>C\u00e9vn\u00ed regenerace<\/strong> \u2014 migrace endoteli\u00e1ln\u00edch bun\u011bk, tvorba kapil\u00e1r a v\u00fdzkum ischemie<\/li>\n<li><strong>Srovn\u00e1vac\u00ed v\u00fdzkum peptid\u016f<\/strong> \u2014 srovn\u00e1n\u00ed s BPC-157 jako kanonick\u00fdm lok\u00e1ln\u00edm hojiv\u00fdm kompar\u00e1torem, nebo s <a href=\"https:\/\/medsbase.com\/cs\/igf-1-lr3-peptide-guide\/\">IGF-1 LR3<\/a> a <a href=\"https:\/\/medsbase.com\/cs\/ipamorelin-cjc-1295-stack-guide\/\">Ipamorelin\/CJC-1295<\/a> ve v\u00fdzkumu r\u016fstov\u00fdch faktor\u016f. Viz na\u0161e <a href=\"https:\/\/medsbase.com\/cs\/bpc-157-vs-tb-500-comparison-guide\/\">srovn\u00e1n\u00ed BPC-157 vs TB-500<\/a> pro p\u0159\u00edm\u00e9 srovn\u00e1n\u00ed.<\/li>\n<\/ul>\n<p>Pro \u0161ir\u0161\u00ed kontext, kde se TB-500 nach\u00e1z\u00ed v r\u00e1mci hojiv\u00fdch peptid\u016f, viz <a href=\"https:\/\/medsbase.com\/cs\/best-peptides-for-muscle-recovery\/\">nejlep\u0161\u00ed peptidy pro regeneraci sval\u016f<\/a> souhrnn\u00fd \u010dl\u00e1nek a dopl\u0148kov\u00e9 v\u00fdzkumn\u00e9 slou\u010deniny v <a href=\"https:\/\/medsbase.com\/cs\/peptides\/\">katalogu peptid\u016f<\/a>.<\/p>\n<h2>Dostupn\u00e9 s\u00edly a koncentrace<\/h2>\n<p>MedsBase nab\u00edz\u00ed TB-500 (syntetick\u00fd Thymosin Beta-4) v n\u00e1sleduj\u00edc\u00edch lyofilizovan\u00fdch velikostech vialek. Ka\u017ed\u00e1 varianta je dod\u00e1v\u00e1na v balen\u00ed po 10, 20 nebo 30 vialk\u00e1ch s \u00fapln\u00fdmi pokyny pro rekonstituci:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">S\u00edla vialky<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Typick\u00e9 pou\u017eit\u00ed<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Velikosti balen\u00ed<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>2 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Pilotn\u00ed v\u00fdzkum, titrace nebo kr\u00e1tk\u00e9 protokoly<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 nebo 30 vialek<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standardn\u00ed v\u00fdzkumn\u00e1 s\u00edla, odpov\u00edd\u00e1 b\u011b\u017en\u00fdm protokol\u016fm s d\u00e1vkou 2\u20132,5 mg na aplikaci<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 nebo 30 vialek<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Roz\u0161\u00ed\u0159en\u00fd v\u00fdzkum, hromadn\u00e1 p\u0159\u00edprava, nejni\u017e\u0161\u00ed cena za mg<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 nebo 30 vialek<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>V\u0161echny t\u0159i s\u00edly jsou stejn\u00e9 chemick\u00e9 formy (lyofilizovan\u00fd pr\u00e1\u0161ek, \u010distota 99%+ HPLC). Vialky s vy\u0161\u0161\u00edm obsahem mg nab\u00edzej\u00ed ni\u017e\u0161\u00ed cenu za mg a jsou obecn\u011b preferov\u00e1ny, kdy\u017e v\u00fdzkumn\u00edci modeluj\u00ed d\u00e1vku 2\u20132,5 mg na aplikaci pou\u017e\u00edvanou ve v\u011bt\u0161in\u011b publikovan\u00fdch protokol\u016f TB-500.<\/p>\n<h2>Jak se srovn\u00e1v\u00e1 \u2014 TB-500 vs BPC-157<\/h2>\n<p>TB-500 a <a href=\"https:\/\/medsbase.com\/cs\/bpc-157\/\">BPC-157<\/a> jsou dva nej\u010dast\u011bji citovan\u00e9 hojiv\u00e9 v\u00fdzkumn\u00e9 peptidy. \u010casto jsou studov\u00e1ny spole\u010dn\u011b, proto\u017ee jejich mechanismy jsou sp\u00ed\u0161e komplement\u00e1rn\u00ed ne\u017e p\u0159ekr\u00fdvaj\u00edc\u00ed se \u2014 BPC-157 p\u016fsob\u00ed lok\u00e1ln\u011b prost\u0159ednictv\u00edm upregulace r\u016fstov\u00fdch faktor\u016f, TB-500 p\u016fsob\u00ed syst\u00e9mov\u011b prost\u0159ednictv\u00edm aktinu a angiogeneze.<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Krit\u00e9rium<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">TB-500 (Thymosin Beta-4)<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">BPC-157<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>D\u00e9lka<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">43 aminokyselin (~4,963 Da)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">15 aminokyselin (~1,419 Da)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Prim\u00e1rn\u00ed mechanismus<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Sekvestrace G-aktinu, angiogeneze, TGF-beta<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">VEGF + NO + upregulace receptoru GH<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Distribuce<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Syst\u00e9mov\u00e9, \u0161iroce distribuovan\u00e9<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Lokalizovan\u011bj\u0161\u00ed v m\u00edst\u011b injekce<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Typick\u00e1 v\u00fdzkumn\u00e1 d\u00e1vka<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">2\u20132,5 mg dvakr\u00e1t t\u00fddn\u011b, 4\u20136 t\u00fddn\u016f nasycovac\u00ed d\u00e1vka<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">250\u2013500 mcg, 1\u20132x denn\u011b<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Nejsiln\u011bj\u0161\u00ed v\u00fdzkumn\u00fd sign\u00e1l<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Srde\u010dn\u00ed, syst\u00e9mov\u00e9 svaly, c\u00e9vn\u00ed, vlasy<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u0160lachy, vazy, st\u0159evn\u00ed bari\u00e9ra<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Kombinov\u00e1n\u00ed<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u010casto pod\u00e1v\u00e1no spole\u010dn\u011b s BPC-157<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u010casto pod\u00e1v\u00e1no spole\u010dn\u011b s TB-500<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Pro \u00fapln\u00e9 metodologick\u00e9 srovn\u00e1n\u00ed a kdy v\u00fdzkumn\u00edci vol\u00ed jeden p\u0159ed druh\u00fdm, p\u0159e\u010dt\u011bte si <a href=\"https:\/\/medsbase.com\/cs\/bpc-157-vs-tb-500-comparison-guide\/\">BPC-157 vs TB-500: kter\u00fd hojiv\u00fd peptid pro v\u00e1\u0161 rekonvalen\u010dn\u00ed c\u00edl<\/a>.<\/p>\n<h2>Skladov\u00e1n\u00ed a rekonstituce<\/h2>\n<p><strong>P\u0159ed rekonstituci:<\/strong> lyofilizovan\u00e9 lahvi\u010dky skladujte v chladni\u010dce p\u0159i 2\u20138 \u00b0C v p\u016fvodn\u00edm obalu. Lyofilizovan\u00fd TB-500 je za t\u011bchto podm\u00ednek stabiln\u00ed a\u017e 36 m\u011bs\u00edc\u016f. Vyvarujte se cykl\u016fm zmrazov\u00e1n\u00ed a rozmrazov\u00e1n\u00ed pr\u00e1\u0161ku.<\/p>\n<p><strong>Postup rekonstituce:<\/strong> Injektujte bakteriostatickou vodu po bo\u010dn\u00ed st\u011bn\u011b lahvi\u010dky s peptidem (ne p\u0159\u00edmo na lyofilizovan\u00fd kol\u00e1\u010d) podle v\u00fd\u0161e uveden\u00e9 tabulky \u0159ed\u011bn\u00ed. Jemn\u011b zakru\u017ete \u2013 <strong>ne<\/strong> prot\u0159epejte a nechte 5\u201310 minut pro \u00fapln\u00e9 rozpu\u0161t\u011bn\u00ed. Spr\u00e1vn\u011b rekonstituovan\u00fd roztok by m\u011bl b\u00fdt \u010dir\u00fd a bezbarv\u00fd.<\/p>\n<p><strong>Po rekonstituci:<\/strong> Skladujte v chladni\u010dce p\u0159i 2\u20138 \u00b0C a pou\u017eijte do 30 dn\u016f pro optim\u00e1ln\u00ed stabilitu. Nepou\u017e\u00edvejte zmra\u017een\u00fd rekonstituovan\u00fd roztok \u2013 cykly zmrazov\u00e1n\u00ed a rozmrazov\u00e1n\u00ed degraduj\u00ed integritu peptidu. Zlikvidujte jakoukoli lahvi\u010dku projevuj\u00edc\u00ed z\u00e1kal, sra\u017eeniny nebo zm\u011bnu barvy.<\/p>\n<h2 id=\"faqs\">\u010casto kladen\u00e9 dotazy<\/h2>\n<h3>K \u010demu se pou\u017e\u00edv\u00e1 TB-500 ve v\u00fdzkumu?<\/h3>\n<p>TB-500 se pou\u017e\u00edv\u00e1 v laboratorn\u00edm v\u00fdzkumu zam\u011b\u0159en\u00e9m na opravu kostern\u00edho svalstva, regeneraci srde\u010dn\u00ed tk\u00e1n\u011b, hojen\u00ed \u0161lach a vaz\u016f, hojen\u00ed ran, v\u00fdzkum r\u016fstov\u00e9ho cyklu vlas\u016f, c\u00e9vn\u00ed reparaci a syst\u00e9movou regeneraci tk\u00e1n\u00ed. Je <strong>ne<\/strong> schv\u00e1leno FDA a je zde prod\u00e1v\u00e1no v\u00fdhradn\u011b pro laboratorn\u00ed v\u00fdzkum.<\/p>\n<h3>Jak se TB-500 li\u0161\u00ed od BPC-157?<\/h3>\n<p>TB-500 je 43-aminokyselinov\u00fd syntetick\u00fd analog Thymosinu Beta-4, kter\u00fd p\u016fsob\u00ed syst\u00e9mov\u011b prost\u0159ednictv\u00edm vazby na G-aktin, angiogeneze a signalizace TGF-beta. BPC-157 je 15-aminokyselinov\u00fd pentadekapeptid p\u016fsob\u00edc\u00ed p\u0159ev\u00e1\u017en\u011b lok\u00e1ln\u011b prost\u0159ednictv\u00edm VEGF, oxidu dusnat\u00e9ho a drah r\u016fstov\u00e9ho hormonu. Tyto dv\u011b l\u00e1tky jsou \u010dasto ve v\u00fdzkumu pod\u00e1v\u00e1ny spole\u010dn\u011b, proto\u017ee jejich mechanismy p\u016fsoben\u00ed se dopl\u0148uj\u00ed.<\/p>\n<h3>Jak\u00e9 je typick\u00e9 v\u00fdzkumn\u00e9 d\u00e1vkov\u00e1n\u00ed TB-500?<\/h3>\n<p>Publikovan\u00e9 preklinick\u00e9 protokoly obvykle pou\u017e\u00edvaj\u00ed 2\u20132,5 mg na d\u00e1vku pod\u00e1vanou dvakr\u00e1t t\u00fddn\u011b po dobu 4\u20136 t\u00fddn\u016f (f\u00e1ze nasycen\u00ed), n\u00e1sledovanou t\u00fddenn\u00ed udr\u017eovac\u00ed f\u00e1z\u00ed. Z 5 mg lahvi\u010dky rekonstituovan\u00e9 2,0 ml bakteriostatick\u00e9 vody z\u00edsk\u00e1me koncentraci 2,5 mg\/ml \u2014 80 d\u00edlc\u016f na U-100 injek\u010dn\u00ed st\u0159\u00edka\u010dce odpov\u00edd\u00e1 2 mg.<\/p>\n<h3>Je TB-500 schv\u00e1leno FDA?<\/h3>\n<p>Ne. TB-500 (syntetick\u00fd Thymosin Beta-4) nen\u00ed schv\u00e1len FDA, EMA, MHRA ani \u017e\u00e1dn\u00fdm jin\u00fdm regul\u00e1torem pro terapeutick\u00e9 pou\u017eit\u00ed u lid\u00ed. Ve\u0161ker\u00e9 TB-500 prod\u00e1van\u00e9 dodavateli pouze pro v\u00fdzkumn\u00e9 \u00fa\u010dely je ur\u010deno pro laboratorn\u00ed v\u00fdzkum a nem\u011blo by b\u00fdt pod\u00e1v\u00e1no lidem.<\/p>\n<h3>Jak se m\u00e1 TB-500 skladovat?<\/h3>\n<p>Lyofilizovan\u00e9 vialky: skladujte v chladni\u010dce p\u0159i 2\u20138 \u00b0C v p\u016fvodn\u00edm obalu, stabilita a\u017e 36 m\u011bs\u00edc\u016f. P\u0159ipraven\u00fd roztok: skladujte v chladni\u010dce p\u0159i 2\u20138 \u00b0C, pou\u017eijte do 30 dn\u016f. P\u0159ipraven\u00fd roztok nezmrazujte \u2014 mrazic\u00ed cykly peptid degraduj\u00ed.<\/p>\n<h3>Jak rekonstituovat TB-500?<\/h3>\n<p>Postupujte podle v\u00fd\u0161e uveden\u00e9ho rekonstitu\u010dn\u00edho sch\u00e9matu. P\u0159idejte bakteriostatickou vodu po stran\u011b lahvi\u010dky (ne p\u0159\u00edmo na lyofilizovan\u00fd pr\u00e1\u0161ek), jemn\u011b zakru\u017ete a nechte 5\u201310 minut pro \u00fapln\u00e9 rozpu\u0161t\u011bn\u00ed. Ne <strong>ne<\/strong> prot\u0159ep\u00e1vejte lahvi\u010dku.<\/p>\n<h3>Jak\u00e9 s\u00edly nab\u00edz\u00ed MedsBase?<\/h3>\n<p>MedsBase nab\u00edz\u00ed TB-500 v lyofilizovan\u00fdch lahvi\u010dk\u00e1ch o s\u00edle 2 mg, 5 mg a 10 mg. Ka\u017ed\u00e1 s\u00edla je dostupn\u00e1 v balen\u00edch po 10, 20 nebo 30 lahvi\u010dk\u00e1ch. V\u0161echny lahvi\u010dky maj\u00ed HPLC \u010distotu 99 %+ a certifik\u00e1t o anal\u00fdze je k dispozici na vy\u017e\u00e1d\u00e1n\u00ed.<\/p>\n<h3>Mohou b\u00fdt TB-500 a BPC-157 ve v\u00fdzkumu kombinov\u00e1ny?<\/h3>\n<p>Ano. TB-500 a BPC-157 pat\u0159\u00ed mezi nej\u010dast\u011bji kombinovan\u00e9 peptidy v preklinick\u00e9m v\u00fdzkumu. Jejich mechanismy p\u016fsoben\u00ed se dopl\u0148uj\u00ed (syst\u00e9mov\u00e9 vs. lok\u00e1ln\u00ed, vazba na aktin vs. upregulace r\u016fstov\u00fdch faktor\u016f) a kombinovan\u00e9 protokoly se \u010dasto objevuj\u00ed ve v\u00fdzkumu pojivov\u00fdch tk\u00e1n\u00ed a regenerace sval\u016f. Viz na\u0161e <a href=\"https:\/\/medsbase.com\/cs\/bpc-157-vs-tb-500-comparison-guide\/\">srovn\u00e1vac\u00edm pr\u016fvodci<\/a>.<\/p>\n<h3>Pro\u010d se TB-500 d\u00e1vkuje m\u00e9n\u011b \u010dasto ne\u017e BPC-157?<\/h3>\n<p>TB-500 m\u00e1 del\u0161\u00ed cirkula\u010dn\u00ed polo\u010das a syst\u00e9mov\u011b se distribuuje, proto publikovan\u00e9 v\u00fdzkumn\u00e9 protokoly obvykle d\u00e1vkuj\u00ed dvakr\u00e1t t\u00fddn\u011b. BPC-157 je v\u00edce lokalizovan\u00fd a b\u011b\u017en\u011b se d\u00e1vkuje jednou nebo dvakr\u00e1t denn\u011b ve stejn\u00fdch typech v\u00fdzkumu modeluj\u00edc\u00edch poran\u011bn\u00ed.<\/p>\n<h3>Zp\u016fsobuje TB-500 ve v\u00fdzkumu vedlej\u0161\u00ed \u00fa\u010dinky?<\/h3>\n<p>Publikovan\u00fd preklinick\u00fd v\u00fdzkum uv\u00e1d\u00ed rozumn\u00fd bezpe\u010dnostn\u00ed profil p\u0159i typick\u00fdch v\u00fdzkumn\u00fdch d\u00e1vk\u00e1ch. Dlouhodob\u00e9 \u00fadaje o bezpe\u010dnosti u lid\u00ed nejsou k dispozici, proto\u017ee TB-500 nebyl schv\u00e1len pro lidsk\u00e9 pou\u017eit\u00ed a je prod\u00e1v\u00e1n pouze pro v\u00fdzkumn\u00e9 \u00fa\u010dely. Publikovan\u00e9 toxikologick\u00e9 pr\u00e1ce neidentifikovaly ne\u017e\u00e1douc\u00ed sign\u00e1ly p\u0159i standardn\u00edch v\u00fdzkumn\u00fdch d\u00e1vk\u00e1ch.<\/p>\n<h3>Je TB-500 stejn\u00fd jako pln\u00fd Thymosin Beta-4?<\/h3>\n<p>TB-500 je uv\u00e1d\u011bn na trh jako syntetick\u00e1 forma Thymosinu Beta-4 (TB4). V komer\u010dn\u00ed nab\u00eddce pouze pro v\u00fdzkumn\u00e9 \u00fa\u010dely je to, co je prod\u00e1v\u00e1no jako \u201cTB-500\u201d, typicky pln\u00e1 43-aminokyselinov\u00e1 molekula TB4 syntetizovan\u00e1 chemicky. N\u011bkter\u00e1 literatura ozna\u010duje krat\u0161\u00ed fragmenty v\u00e1zaj\u00edc\u00ed aktin (LKKTETQ) jako funk\u010dn\u00ed analogy TB4 v \u00fazk\u00fdch v\u00fdzkumn\u00fdch kontextech, ale pln\u011b dlouh\u00fd TB4 je dominantn\u00ed v\u00fdzkumnou formou.<\/p>\n<h3>Jak\u00fd je polo\u010das TB-500?<\/h3>\n<p>TB-500 (syntetick\u00fd Thymosin Beta-4) m\u00e1 v preklinick\u00e9m v\u00fdzkumu odhadovan\u00fd s\u00e9rov\u00fd polo\u010das n\u011bkolik dn\u00ed \u2013 v\u00fdrazn\u011b del\u0161\u00ed ne\u017e v\u011bt\u0161ina GHRP a lok\u00e1ln\u011b p\u016fsob\u00edc\u00edch hojiv\u00fdch peptid\u016f, jako je BPC-157. Tento prodlou\u017een\u00fd polo\u010das podporuje m\u00e9n\u011b \u010dast\u00e9 d\u00e1vkovac\u00ed re\u017eimy obvykle pou\u017e\u00edvan\u00e9 ve v\u00fdzkumn\u00fdch protokolech T\u03b24.<\/p>\n<h3>Jak dlouho trv\u00e1, ne\u017e se projev\u00ed \u00fa\u010dinky TB-500 v preklinick\u00e9m v\u00fdzkumu?<\/h3>\n<p>Preklinick\u00e9 studie vyu\u017e\u00edvaj\u00edc\u00ed Thymosin Beta-4 v modelech srde\u010dn\u00ed, kostern\u00ed svaloviny a pojivov\u00e9 tk\u00e1n\u011b obvykle pozoruj\u00ed m\u011b\u0159iteln\u00e9 \u00fa\u010dinky b\u011bhem 2\u20134 t\u00fddenn\u00edch v\u00fdzkumn\u00fdch cykl\u016f. Syst\u00e9mov\u00e1 distribuce a del\u0161\u00ed polo\u010das ve srovn\u00e1n\u00ed s lok\u00e1ln\u011b p\u016fsob\u00edc\u00edmi peptidy znamenaj\u00ed, \u017ee \u010dasov\u00e9 r\u00e1mce v\u00fdzkumu TB-500 jsou obecn\u011b del\u0161\u00ed.<\/p>\n<h3>Mohu si objednat TB-500 pro mezin\u00e1rodn\u00ed dopravu?<\/h3>\n<p>Ano. MedsBase expeduje TB-500 po cel\u00e9m sv\u011bt\u011b prost\u0159ednictv\u00edm na\u0161\u00ed specializovan\u00e9 s\u00edt\u011b pro p\u0159epravu peptid\u016f. Objedn\u00e1vky obsahuj\u00edc\u00ed pouze peptidy maj\u00ed n\u00e1rok na na\u0161i samostatnou p\u0159epravn\u00ed slu\u017ebu pro peptidy. V\u0161echny z\u00e1silky jsou odes\u00edl\u00e1ny v termoregulovan\u00e9m balen\u00ed s pln\u00fdm sledov\u00e1n\u00edm.<\/p>\n<p class=\"medsbase-bundle-link-2026-05-01\" data-marker=\"mb-bundle-link-peptide-healing-stack\">TB-500 se nej\u010dast\u011bji pou\u017e\u00edv\u00e1 spole\u010dn\u011b s BPC-157 \u2014 angiogeneze (BPC-157) spolu s opravou cytoskeletu (TB-500) poskytuje rychlej\u0161\u00ed a \u00fapln\u011bj\u0161\u00ed regeneraci m\u011bkk\u00fdch tk\u00e1n\u00ed ne\u017e ka\u017ed\u00fd peptid samostatn\u011b; na\u0161e <a href=\"\/cs\/peptide-healing-stack\/\">Peptide Healing Stack (BPC-157 5 mg + TB-500 5 mg + bakteriostatick\u00e1 voda)<\/a> expeduje doporu\u010den\u00fd protokol v jedn\u00e9 z\u00e1silce.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2>Dal\u0161\u00ed peptidy pro v\u00fdzkum regenerace a v\u00fdkonnosti<\/h2>\n<ul>\n<li><a href=\"\/cs\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Body Protection Compound \u2014 v\u00fdzkum regenerace \u0161lach, vaz\u016f a st\u0159ev<\/li>\n<li><a href=\"\/cs\/ipamorelin\/\"><strong>Ipamorelin<\/strong><\/a> \u2014 Selektivn\u00ed agonista ghrelinu \u2014 \u010dist\u00fd pulz r\u016fstov\u00e9ho hormonu bez kortizolu\/prolaktinu<\/li>\n<li><a href=\"\/cs\/cjc-1295-with-dac\/\"><strong>CJC-1295 with DAC<\/strong><\/a> \u2014 Analog GHRH s prodlou\u017een\u00fdm polo\u010dasem<\/li>\n<li><a href=\"\/cs\/ghk-cu\/\"><strong>GHK-Cu<\/strong><\/a> \u2014 M\u011b\u010fn\u00fd peptid \u2014 v\u00fdzkum regenerace k\u016f\u017ee a pojivov\u00e9 tk\u00e1n\u011b<\/li>\n<li><a href=\"\/cs\/igf-1-lr3\/\"><strong>IGF-1 LR3<\/strong><\/a> \u2014 Long-R3 IGF-1 analog \u2014 anabolick\u00fd \/ regenera\u010dn\u00ed v\u00fdzkum<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Dal\u0161\u00ed \u010dten\u00ed<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Seznamte se s v\u00fdzkumem tohoto peptidu<\/strong><\/p>\n<p style=\"margin: 0;\">P\u0159e\u010dt\u011bte si n\u00e1\u0161 kompletn\u00ed pr\u016fvodce zalo\u017een\u00fd na d\u016fkazech: <a href=\"https:\/\/medsbase.com\/cs\/tb-500-thymosin-beta-4-peptide-guide\/\"><strong>TB-500 \u2014 mechanismus \u00fa\u010dinku, klinick\u00e1 data a perspektivy<\/strong><\/a>. Pokr\u00fdv\u00e1 mechanismus \u00fa\u010dinku, publikovan\u00e1 v\u00fdzkumn\u00e1 data, obvykl\u00e9 rozsahy v\u00fdzkumn\u00e9ho d\u00e1vkov\u00e1n\u00ed, protokoly pro rekonstituci, mo\u017enosti kombinace a pozn\u00e1mky k bezpe\u010dnosti\/kontraindikac\u00edm.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Podporuje bun\u011b\u010dnou regeneraci<br \/>\n\u2705 Zlep\u0161uje modelov\u00e1n\u00ed tk\u00e1n\u00ed<br \/>\n\u2705 Podporuje aktivitu fibroblast\u016f<br \/>\n\u2705 Stimuluje angiogenn\u00ed signalizaci<br \/>\n\u2705 Zlep\u0161uje stabilitu extracelul\u00e1rn\u00ed matrix<\/p>\n<p><strong>TB-500<\/strong> obsahuje syntetickou peptidovou slou\u010deninu.<\/p>","protected":false},"featured_media":70987,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5441,5442,5443],"class_list":{"0":"post-68758","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-peptides","7":"product_tag-peptide","8":"product_tag-tb-500","9":"product_tag-thymosin-beta-4","11":"first","12":"instock","13":"shipping-taxable","14":"purchasable","15":"product-type-variable","16":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product\/68758","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/comments?post=68758"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media\/70987"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media?parent=68758"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_brand?post=68758"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat?post=68758"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_tag?post=68758"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}